Isoform selective PI3K p110δ and Hck inhibitors are available and may be deployed to prevent the activation of tumor invasion by co-migrating TAMs, which not only provide EGF to stimulate tumor cell motility, but also dig tunnels into the surrounding matrix through which tumor cells can escape. Here, HCK is linked to neoplasm.